Manuel Aivado - 30 Mar 2022 Form 4/A - Amendment Insider Report for AILERON THERAPEUTICS INC (ALRN)

Role
President and Chief Executive Officer, Director
Signature
/s/ Richard Wanstall, attorney in fact for Manuel Aivado
Issuer symbol
ALRN
Transactions as of
30 Mar 2022
Transactions value $
$0
Form type
4/A - Amendment
Filing time
30 Mar 2022, 20:33:52 UTC
Date Of Original Report
24 Mar 2022
Previous filing
24 Mar 2022
Next filing
22 Aug 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALRN Stock Option (right to buy) Award $0 +1.13M $0.00 1.13M 30 Mar 2022 Common Stock 1.13M $0.48 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amendment is being filed to correct the date of grant and the exercise price for the stock option reported on a Form 4 filed by the reporting person on March 24, 2022. This option became effective on March 30, 2022.
F2 The shares underlying the option are scheduled to vest in equal monthly installments through March 30, 2026.

Remarks:

President and Chief Executive Officer